Welcome to our dedicated page for Rocket Lab Usa SEC filings (Ticker: RKLB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Rocket science may be hard, but finding crucial numbers in Rocket Lab USA Inc. (RKLB) filings shouldn’t be. Electron launch margins, Neutron development costs, even contract backlog disclosures are buried across hundreds of pages. Our platform delivers clear answers by pairing every SEC document with AI-powered summaries that translate aerospace jargon into plain English.
Need the Rocket Lab quarterly earnings report 10-Q filing or want the Rocket Lab annual report 10-K simplified? They’re here alongside real-time Rocket Lab insider trading Form 4 transactions. Stock Titan’s AI filters risk-factor updates, flags engine R&D spend, and points you straight to launch cadence tables—saving hours of manual review. You can also track:
- Rocket Lab Form 4 insider transactions real-time to monitor executive stock moves before material launches.
- Rocket Lab proxy statement executive compensation for insight into incentive structures tied to flight milestones.
- Rocket Lab 8-K material events explained so new contract wins or launch anomalies never go unnoticed.
Every filing type—10-Q, 10-K, 8-K, S-3, DEF 14A—is updated the moment EDGAR posts. Interactive tools let professionals compare period-over-period R&D outlays, analyze segment revenue from Launch Services vs. Space Systems, or export tables for models. Whether you’re seeking “understanding Rocket Lab SEC documents with AI” or a quick read of a “Rocket Lab earnings report filing analysis,” this page answers the questions investors actually ask and turns dense disclosures into actionable space-industry intelligence.
Rocket Lab Corp (RKLB) Chief Financial Officer Adam Spice reported stock sales in a Form 4 filing. On 11/22/2025, he sold 15,633 shares of common stock in a sell-to-cover transaction at a weighted average price of $40.0247 to satisfy tax withholding from vested restricted stock units. On 11/24/2025, he sold an additional 46,737 shares at a weighted average price of $40.8576 and 257 shares at a weighted average price of $41.3495, also reported as sales.
After these transactions, Spice beneficially owned 1,995,373 Rocket Lab common shares, which includes 111 shares acquired under the company’s 2021 Employee Stock Purchase Plan in transactions exempt under Rule 16b-3. The reported sale prices reflect weighted averages for multiple trades within specified price ranges.
Rocket Lab Corp (RKLB) reported an insider stock transaction by its Chief Operations Officer, Frank Klein. On 11/24/2025, Klein sold 10,430, 31,181, and 171 shares of common stock in three separate transactions at weighted average prices of $40.0247, $40.8576, and $41.3495 per share, respectively.
The filing states these sales were part of a “sell-to-cover” arrangement to satisfy tax withholding obligations related to vesting restricted stock units previously granted to him. After these transactions, Klein beneficially owned 1,274,223 Rocket Lab common shares, held directly.
Rocket Lab Corp (RKLB) reported insider share sales by its SVP General Counsel in a Form 4 filing. On 11/24/2025, the executive sold 7,143, 21,355, and 117 shares of common stock in three separate transactions at weighted average prices of $40.0247, $40.8576, and $41.3495, respectively. These sales were executed as part of a sell-to-cover transaction to satisfy tax withholding obligations related to vesting restricted stock units.
Following these trades, the reporting person directly beneficially owns 461,014 Rocket Lab common shares. The prices reported reflect weighted averages for shares sold in multiple trades within the noted price ranges, and detailed breakdowns are available on request to the company or regulators.
Rocket Lab Corp (RKLB) CEO and Director Peter Beck reported equity awards and related share sales. On 11/15/2025, he was granted 132,426 restricted stock units (RSUs)$0.0. These RSUs vest over time, with 1/16 vesting on November 22, 2025 and 1/16 on each March 1, May 22, August 22 and November 22 thereafter, subject to his continuous service.
On 11/24/2025, Beck sold 4,707, 14,073 and 77 common shares in three separate transactions as sell-to-cover sales to satisfy tax withholding related to RSU vesting. The weighted average sale prices were $40.0247, $40.8576 and $41.3495, each executed in multiple trades within specified price ranges. After these transactions, he directly owned 902,942 Rocket Lab shares and was also reported as an indirect beneficial owner of 2,500,000 shares held by a family trust.
Rocket Lab Corp director Jon A. Olson reported selling 60,400 shares of Rocket Lab common stock in an open-market transaction on 11/20/2025 at a weighted average price of $45.0244 per share.
Following this sale, Olson directly beneficially owned 375,835 Rocket Lab shares. The filing notes that the reported price is a weighted average, as the shares were sold in multiple trades at prices ranging from $45 to $45.110 per share.
Rocket Lab (RKLB) reported Q3 2025 results with total revenue of $155.1 million, up from $104.8 million a year ago. Gross profit rose to $57.3 million, while operating loss was $59.0 million. A tax benefit drove net loss to $18.3 million, an improvement from a $51.9 million loss in the prior year period.
Liquidity strengthened: cash and cash equivalents reached $807.9 million, supported by $865.5 million in proceeds from at-the-market equity offerings year‑to‑date. Stockholders’ equity increased to $1.28 billion from $382.5 million at year‑end 2024.
GEOST acquisition closed on August 12, adding preliminary identifiable intangibles of $183.3 million and goodwill of $146.7 million. Consideration totaled $289.6 million, including $133.7 million cash and 3,057,588 shares valued at $137.7 million, plus $18.3 million contingent consideration. Q3 included $5.0 million revenue and a $2.1 million operating loss from GEOST.
Backlog was $1.096 billion as of September 30, 2025, with about 57% expected to convert within 12 months. For the nine months, revenue was $422.1 million versus $303.8 million in 2024. As of November 5, 2025, common shares outstanding were 534,156,333.
Rocket Lab Corporation furnished a press release announcing financial results for the third quarter ended September 30, 2025, as Exhibit 99.1 to an 8-K. The Item 2.02 information is furnished and not deemed filed under the Exchange Act.
The company also disclosed that director Matt Ocko notified Rocket Lab of his resignation from the Board, effective November 30, 2025. The filing states his resignation is not due to any dispute or disagreement regarding operations, policies, or practices.
Adam C. Spice, Rocket Lab Corp (RKLB) Chief Financial Officer, reported option exercises and share sales in mid-September 2025. On 09/18/2025 Mr. Spice exercised an employee stock option with a $1.09 exercise price covering 1,867,496 shares, triggering acquisition of those common shares. The filing reports a subsequent "sell-to-cover" disposition on 09/19/2025 of 862,588 shares at a weighted-average price of $47.9941 and an additional sale of 12,000 shares at a weighted-average price of $48.8484 to satisfy the exercise cost and tax withholding. After these transactions, the reporting person beneficially owned 3,254,155 shares including 1,867,496 underlying the exercised option and 2,057,889 shares held directly following the final sale.
Alexander R. Slusky, a director of Rocket Lab Corp (RKLB), reported on Form 4 that on 09/18/2025 he disposed of 35,000 shares of Rocket Lab common stock as a bona fide gift to a charitable entity. After the gift, Mr. Slusky directly beneficially owns 88,849 shares and indirectly owns 534,675 shares through Abalone Cove LLLP, a partnership where he is the sole general partner and, together with his spouse, the sole limited partners. The Form 4 was signed by an attorney-in-fact on 09/22/2025.